Cannabidiol – commonly abbreviated to CBD – is a naturally-occuring cannabinoid; a chemical compound found in cannabis.
When isolated from other cannabinoids, CBD does not cause the side effects commonly associated with cannabis, in particular the characteristic high which is caused by tetrahydrocannabinol or THC.
Canaxen Products Contain 0% THC
THC is illegal in the UK. However, dietary supplements like CanaXen which contain CBD are allowed for sale so long as Companies follow strict guidelines.
CBD products provide the significant benefits of cannabis and hemp, without exposing the user to the negative effects of THC.
CBD and THC levels vary among different cannabis plants.
As typically grown for recreational use, cannabis often contains far more THC than CBD. However, by using selective breeding techniques cannabis breeders have created varieties with high levels of CBD and near-zero levels of THC. The hemp plant has taken second stage for many decades and been used for industrial and commercial uses. Many varieties do not contain much CBD or THC but some are known to contain high levels of CBD while keeping the THC at legal levels – the EU legal breeds we use belong to the latter category.
CBD is non-psychoactive.
CBD does not cause a high. This gives CBD a significant advantage as a nutritional supplement as it minimises negative side effects.
CBD is non-psychoactive because it does not act on the same neural pathways as THC. These pathways, called CB1 receptors, are highly concentrated in the brain and are responsible for the mind-altering effects of THC.
A 2011 review published in the journal Current Drug Safety concluded that CBD “does not interfere with several psychomotor and psychological functions.” The authors add that several studies suggest that CBD is “well tolerated and safe” in humans, even at high doses.
Understanding the ECS
We all have an endogenous cannabinoid system inside our bodies.
It is named after the plant associated with its discovery and is arguably the most significant physiologic system known to affect our health and wellbeing.
We have endocannabinoids in the brain, the vital organs, connective tissues, immune cells and glands and they work to restore balance to our bodies to make us feel better.
Scientists have compared the genetic changes in cannabinoid receptors across a huge range of species – humans included, and they believe the endocannabinoid system first evolved around 600 million years ago. Yet understanding the way that these cannabinoids, cells and other systems interact is still very much a work in progress.
What we do know is that the endocannabinoid system is something like a bridge between body and mind. It is a cellular process. Our cells need to recycle themselves and regenerate to help fight any bad or malignant cells and minimise any damage and pain we feel.
Endocannabinoids and cannabinoids can be found around the points on the body where there might be an injury or an ache. They help stabilise nerve cells, calm local immune cells and reduce inflammation. Read more
Bodies in Balance
As well as helping rebalance our bodies functionality, cannabinoids may help rebalance our minds. They are said to stimulate specific regions of the adult brain connected to creativity and open-mindedness, all of which contributes to a broader sense of wellbeing.
The problem is that most of us do not nourish the endocannabinoid system within our body. It is only when faced with aches, pains and perhaps more serious ailments that we look for a quick fix to regain our equilibrium. Cannabinoids are essential to that process.
Cannabis is mainly used as a recreational substance and is the most widely used illegal drug in the UK. Yet it also has a vast array of natural medicinal and industrial uses, which is why its cultivation is heavily regulated and controlled.
Many people believe cannabis can be a valuable medicine and a potential treatment for ailments from skin irritations to pain relief, thanks to the active ingredients, the phytocannabinoids. Phytocannabinoids are chemicals found in plants known to work on cannabinoid receptors.
The most well-known of these is delta-9-tetrahydrocannabinol, or THC, but researchers are becoming increasingly interested in CBD for its potential therapeutic benefits. The non-psychoactive component CBD, is legal and fascinating to research. CBD is one of around 80 different natural cannabinoids that can be harvested from the cannabis plant and is legal everywhere and doesn’t make you “high”.
Research into the health benefits of CBD is underway in the scientific community. It has been for several years now. Many CBD industry insiders eagerly await a string of reports due to be published in the short to medium term. Trials are underway to test cannabis-based drugs for a variety of ailments, illnesses and conditions.
It is a fact that THC and CBD are the active ingredients of a prescription drug called Sativex, which is used to relieve the pain of muscle spasms in multiple sclerosis.
Another cannabinoid based drug, Nabilone, is sometimes used to relieve sickness in people having chemotherapy for cancer. Cannabis based drugs are also being tested for other conditions including cancer pain, the eye disease glaucoma, appetite loss in people with HIV or AIDS, and epilepsy in children.
We will not know for certain these treatments are effective until the trials have finished and research made public.
We know it is complicated, which is why we will continue to provide interested consumers and our returning customers with as much information about cannabidiol and cannabis derived compounds as possible. Within the restrictions of current UK law.